JPMorgan Chase & Co. raised its stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG – Free Report) by 275.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 163,618 shares of the company’s stock after purchasing an additional 120,005 shares during the quarter. JPMorgan Chase & Co. owned about 0.09% of BrightSpring Health Services worth $2,402,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. FMR LLC increased its stake in shares of BrightSpring Health Services by 17.2% in the third quarter. FMR LLC now owns 18,169,187 shares of the company’s stock worth $266,724,000 after acquiring an additional 2,664,582 shares during the period. Lisanti Capital Growth LLC acquired a new stake in shares of BrightSpring Health Services in the third quarter worth $4,659,000. Walleye Capital LLC increased its stake in shares of BrightSpring Health Services by 388.0% in the third quarter. Walleye Capital LLC now owns 167,112 shares of the company’s stock worth $2,453,000 after acquiring an additional 132,869 shares during the period. Assenagon Asset Management S.A. acquired a new stake in shares of BrightSpring Health Services in the third quarter worth $1,822,000. Finally, State Street Corp increased its stake in shares of BrightSpring Health Services by 7.4% in the third quarter. State Street Corp now owns 1,239,628 shares of the company’s stock worth $18,198,000 after acquiring an additional 85,464 shares during the period.
Analysts Set New Price Targets
A number of analysts recently issued reports on BTSG shares. Morgan Stanley increased their price target on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. KeyCorp started coverage on shares of BrightSpring Health Services in a report on Friday, October 11th. They set a “sector weight” rating on the stock. CJS Securities started coverage on shares of BrightSpring Health Services in a report on Thursday, December 12th. They set an “outperform” rating and a $27.00 price target on the stock. Bank of America increased their price target on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Finally, Guggenheim increased their price objective on shares of BrightSpring Health Services from $15.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. One investment analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $18.65.
BrightSpring Health Services Stock Performance
NASDAQ:BTSG opened at $20.89 on Wednesday. The company’s 50-day moving average price is $18.19 and its 200-day moving average price is $15.36. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The company has a market cap of $3.64 billion and a P/E ratio of -80.35. BrightSpring Health Services, Inc. has a twelve month low of $7.85 and a twelve month high of $21.34.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last released its quarterly earnings data on Friday, November 1st. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.07). BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The firm had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.72 billion. The business’s quarterly revenue was up 28.8% compared to the same quarter last year. On average, sell-side analysts forecast that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.
BrightSpring Health Services Profile
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Featured Stories
- Five stocks we like better than BrightSpring Health Services
- Investing in Commodities: What Are They? How to Invest in Them
- SAP’s Strong Momentum: A Bullish Setup for Investors
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What is a Secondary Public Offering? What Investors Need to Know
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Want to see what other hedge funds are holding BTSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BrightSpring Health Services, Inc. (NASDAQ:BTSG – Free Report).
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.